Lisata Therapeutics earnings were -$19.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LSTA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$4.7M, up 2.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LSTA reported annual earnings of -$20.0M, with -4.1% growth.
Lisata Therapeutics Earnings Reports & History FAQ
What were Lisata Therapeutics's earnings last quarter?
On LSTA's earnings call on Invalid Date, Lisata Therapeutics (NASDAQ: LSTA) reported Q1 2025 earnings per share (EPS) of -$0.55, up 15.38% year over year. Total LSTA earnings for the quarter were -$4.72 million. In the same quarter last year, Lisata Therapeutics's earnings per share (EPS) was -$0.65.
Is Lisata Therapeutics profitable or losing money?
As of the last Lisata Therapeutics earnings report, Lisata Therapeutics is currently losing money. Lisata Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$19.31 million, a 3.72% decrease year over year.
What was LSTA's earnings growth in the past year?
As of Lisata Therapeutics's earnings date in Invalid Date, Lisata Therapeutics's earnings has grown year over year. LSTA earnings in the past year totalled -$19.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.